SkyCity Entertainment Group Limited (NZX: SKC) Appointment of Chief Financial Officer

SkyCity Entertainment Group Limited is pleased to announce the appointment of Julie Amey to the role of Chief Financial Officer effective from 1 May 2021.

Ms Amey joins SkyCity from Shell Australia where she is currently Vice President Finance Integrated Gas. Ms Amey has held a number of senior finance roles with the Shell Group around the world since 2001, including as Vice President Finance Qatar Shell, Chief Financial Officer for Shell & Turcas A.S. Turkey and Business Finance Manager and Financial Controller for Upstream Middle East in the United Arab Emirates. Prior to joining Shell, Ms Amey held finance roles at Fletcher Challenge Energy, BBC Worldwide Publishing and Deloitte & Touche.

Ms Amey is a University of Waikato graduate and a Chartered Accountant (Chartered Accountants Australia and New Zealand).

Please see the link below for details:

Letter

Source: SkyCity Entertainment Group Limited

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Meridian Energy monthly operating report for July 2022
Cannasouth to launch a pro-rata renounceable rights issue
August 12th Morning Report
2022 Annual Shareholders' Meeting & Director Nominations
Rakon 2022 Annual Meeting Chair's Address and Presentation
VHP - Full year results release
RAKON FY23 Earnings Guidance
August 11th Morning Report
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query